Delivery Order SPE2DB24D3013-SPE2DB25FFQZD
- Not listed
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit quantities. This is a firm fixed-price delivery order valued at $1,344.96, with an ultimate completion date of September 22, 2025. The award is not set-aside and represents a competitive procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $8,041.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (60 count). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a $2,411.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 60-unit quantities, with performance in Conshohocken, Pennsylvania and completion targeted for September 24, 2025. This non-set-aside contract represents a competitive award under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as...
- The Defense Logistics Agency awarded a $21,750.49 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-unit package). This firm fixed-price, competitively awarded contract requires delivery by September 10, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the open competition process through which it was procured. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.48 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This non-competitive, firm fixed price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of Cyclosporine 0.05% eye emulsion. The fixed-price delivery order is valued at $4,622.12 and has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products and medications to federal agencies and healthcare programs. The contract is not set aside for any...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $6,553.50 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 26, 2025, issued on August 25, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for CYCLOSPORINE 0.05% EYE EMULS 60S. The delivery order has a potential value of $7,335.36 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense. The contract does...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQZDDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,730.75 on September 25, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.9 billion global pharmaceutical support vehicle extending through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical supply needs through its substantial portfolio of competitive contract awards with the DLA and its Medical Supply Chain, which span diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support Medical IDC serves multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, providing a flexible contracting mechanism for pharmaceutical procurement across global military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/25/25 |